Central Diabetes Insipidus as a Manifestation of AML Secondary to Temodar Therapy for Pancreatic Neuroendocrine Tumor

Authors

  • Cole R Spresser
  • Allan Fleming

DOI:

https://doi.org/10.17161/kjm.v4i3.11359

Metrics

Metrics Loading ...

Downloads

Published

2011-10-28

Issue

Vol. 4 No. S1 (2011): Supplement: Posters from the 2011 Kansas Chapter of the American College of Physicians

Section

Images

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Spresser, C. R., & Fleming, A. (2011). Central Diabetes Insipidus as a Manifestation of AML Secondary to Temodar Therapy for Pancreatic Neuroendocrine Tumor. Kansas Journal of Medicine, 4(S1). https://doi.org/10.17161/kjm.v4i3.11359